
Conference Coverage
Latest Content

Life After Donation: A Son Reflects on Recovery and Impact

KRAS G12d-Targeted Setidegrasib Shows Activity in Non–Small Cell Lung Cancer

Functional Precision Medicine Advances Pediatric Brain Tumor Care

Nurse and Stage 4 Survivor Bridget Hopkins Shares Her Breast Cancer Journey

The Business of Being Sick With Cancer: A Revelation

Shorts










Podcasts
Videos
All News

FDA approved Lifyorli plus Abraxane, improving survival in platinum-resistant ovarian, fallopian tube and peritoneal cancers.

Five-year ICESECRET data show high recurrence-free rates with cryoablation for small kidney tumors, supporting a minimally invasive treatment option.

Amanda shares how a sudden leukemia diagnosis led to a life-saving transplant and the ongoing challenges of chronic graft-versus-host disease.

Three lifelong friends, all breast cancer survivors, discuss the strength they found in supporting each other.

ctDNA testing could help doctors track response, reduce unnecessary chemo, and identify relapse early for patients with aggressive B cell lymphomas.

For patients navigating a cancer diagnosis, there is a hidden complication that requires vigilance: the risk of a pulmonary embolism.

For me, Colorectal Cancer Awareness Month is about my brother, Jimmy, who died from colorectal cancer at the age of 36.

New findings from the phase 3 SENTRY trial offer encouraging news for patients with myelofibrosis.

Topical HT-001 reduced rash and irritation from EGFR therapies with low levels in the bloodstream and no serious side effects in patients with cancer.

A son shares his decision to become a living liver donor, offering his father a second chance after a cancer diagnosis.

Dr. Amengual outlines how patients with relapsed lymphoma can approach clinical trials, including phases, eligibility and key questions to ask providers.

A couple shares how self advocacy, preparation and caregiver support shaped their experience navigating liver cancer care.

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation.

The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in disease progression risk.

Jonise S. Louis shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of her oncology team.



















